Xiangxue Pharmaceutical Co.,Ltd.

XSEC:300147 Stock Report

Market Cap: CN¥6.5b

Xiangxue PharmaceuticalLtd Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Yonghui Wang

Chief executive officer

CN¥900.0k

Total compensation

CEO salary percentagen/a
CEO tenure14.4yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

CEO

Yonghui Wang (62 yo)

14.4yrs

Tenure

CN¥900,000

Compensation

Mr. Yonghui Wang serves as General Manager and Chairman of Xiangxue Pharmaceutical Co., Ltd. since July 23, 2010. Mr. Wang served as Deputy General Manager of Guangzhou Wanbao Group Industrial Washing Mach...

Leadership Team

NamePositionTenureCompensationOwnership
Yonghui Wang
Chairman & GM14.4yrsCN¥900.00kno data
Xiaoyan Niu
Financial Director2.5yrsCN¥360.00k0.0023%
CN¥ 146.7k
Li Xu
Secretary of the Board of Directors & Non-Independent Directorno dataCN¥240.00k0.030%
CN¥ 2.0m
Lun Zeng
Vice Presidentno dataCN¥960.00k0.060%
CN¥ 3.9m
Guanghua Tan
General Manager of Marketing Center2.5yrsCN¥530.00k0.039%
CN¥ 2.5m
Zhiying Kang
GM of Technology R&Dno dataCN¥240.00k0.046%
CN¥ 3.0m
Feng Lu
Director of Internal Audit2.5yrsCN¥180.00k0.037%
CN¥ 2.4m
Junliang Zhong
Supply Chain General Manager2.5yrsCN¥263.00kno data

2.5yrs

Average Tenure

49yo

Average Age

Experienced Management: 300147's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yonghui Wang
Chairman & GM14.4yrsCN¥900.00kno data
Li Xu
Secretary of the Board of Directors & Non-Independent Director5.5yrsCN¥240.00k0.030%
CN¥ 2.0m
Wen Jin Chen
Director2.4yrsCN¥240.00k0.0091%
CN¥ 586.0k
Zi Yu Mo
Non-Employee Representative Supervisor8.6yrsCN¥320.00k0.027%
CN¥ 1.8m
Wen Hui Tan
Non-Independent Director14.4yrsno data0.020%
CN¥ 1.3m
Jun Hui Chen
Non-Employee Representative Supervisor8.6yrsno datano data
Qingquan Zhou
Independent Director5.5yrsCN¥60.00kno data
Jianhong Tao
Independent Director3.3yrsCN¥60.00kno data
Jie Wu
Independent Director3.3yrsCN¥60.00kno data
Wei Hua Huang
Chairman of the Supervisory Board5.5yrsCN¥280.00k0.028%
CN¥ 1.8m

5.5yrs

Average Tenure

57yo

Average Age

Experienced Board: 300147's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 17:12
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xiangxue Pharmaceutical Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Weina JiangEverbright Securities Co. Ltd.
Juyin HeGF Securities Co. Ltd.
Qi Li ZhangGuosen Securities Co., Ltd.